The U.S. Food and Drug Administration has approved Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis ...

This approval offers a promising new targeted treatment for patients aged 12 and older with C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), ...

For three days inside the Charleston Convention Center, fire, EMS, law enforcement and dispatchers from the tri-county ...

I've been writing about the LG C3 OLED TV since its release in 2023, and it has consistently been a best-seller, thanks to ...

Apellis Pharmaceuticals has made pipeline progress and strengthened its balance sheet. Click here to read an analysis of APLS ...

BornHack is a week-long summer hacker camp in a forest on the Danish island of Fyn, that consistently delivers a very ...

Pirelli has nominated its tyre compounds for the remaining Formula 1 races of 2025, with some changes compared to its ...

Developer Howard Saffan and concert promoter Jim Koplik helped establish the music event in 2021 and are not ready to say ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.

Discover new safety insights on Syfovre for geographic atrophy treatment, as Roger A. Goldberg highlights promising long-term data at ASRS 2025.

We sifted through the Finviz stock screener to compile a list of the top 10 biotech stocks with an upside potential of over ...

As Lollapalooza returns to Chicago’s Grant Park this weekend, organizers are once again turning up the volume on ...